Billionaire Profile
Lam Kong
Global Rank
#1631

Image: mailer_diablo | CC BY-SA 3.0 | via Wikimedia Commons

Lam Kong

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$2.523B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+1.64% (24h)
Age
61
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Lam Kong, a self-made billionaire, is the Chairman and CEO of China Medical System Holdings Ltd., a leading pharmaceutical distributor in China. Born in China, Lam's career spans over two decades, marked by his strategic vision and deep understanding of the healthcare industry. His leadership has been instrumental in the company's growth and its listing on the Hong Kong Stock Exchange, establishing it as a pioneer in distributing essential pharmaceuticals across China. With an estimated net worth of $2.7 billion, Lam has solidified his place among Hong Kong's wealthiest individuals.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Lam Kong's journey began with a focus on education, graduating from Zhanjiang Medical College (now Guangdong Medical University) in 1986 with a bachelor's degree in clinical medicine. This early experience provided a foundation for his deep understanding of the pharmaceutical industry, setting the stage for his future ventures.

Rise to Success

Lam Kong founded China Medical System Holdings Ltd. in 1995. Under his leadership, the company has grown into a major distributor of drugs to thousands of hospitals across China. In 2010, the company went public on the Hong Kong Stock Exchange, a pivotal moment that further propelled its growth.

Key Business Strategies

Lam's success is rooted in several key strategies. His focus on the marketing, sales, and promotion of pharmaceutical products has been critical. He has emphasized producing excellent products and providing professional promotion services to physicians, patients, and manufacturers. China Medical System's largest shareholder of Shanghai-listed Tibet Rhodiola Pharmaceutical. Lam's leadership helped the company to get listed in the Hong Kong Stock Exchange.

Philanthropy

While specific details of Lam Kong's philanthropy are not readily available, his commitment to providing essential pharmaceuticals suggests an underlying concern for the health and well-being of the population. This is evidenced by his company's distribution of crucial medications across China.

Career Milestones

1986

Graduated from Zhanjiang Medical College

Lam received a bachelor's degree in clinical medicine, laying the foundation for his pharmaceutical career.

1995

Founded China Medical System

Lam established the company, marking the beginning of his entrepreneurial venture in the pharmaceutical industry.

2010

China Medical System went public

The company's listing on the Hong Kong Stock Exchange was a significant milestone, fueling its growth.

Philanthropy & Social Impact

Healthcare

Unknown

Undisclosed

No direct philanthropic initiatives found, but his company's focus on distributing essential pharmaceuticals suggests a commitment to public health.

Business Philosophy & Leadership

Leadership Principles

Strategic Vision

Lam Kong is responsible for the creation, implementation and management of the CMS's development and growth strategy.

Industry Expertise

Lam has clinician experience and deep understanding and knowledge of China's pharmaceutical industry.